📄

ApoE-directed CpG nano-immunoadjuvant ameliorates Alzheimer's-like pathology in mice.

active
paper Created: By: unknown Quality: 50% ✓ SciDEX ID: paper-41651379
📄 Paper Details
ApoE-directed CpG nano-immunoadjuvant ameliorates Alzheimer's-like pathology in mice.
Huang X, Sun YY, Qin YR, Chen H, Pan TT et al.
J Control Release PubMed DOI
Abstract

Toll-like receptor 9 (TLR9), expressed in both microglia and neurons of the CNS, represents a promising therapeutic target for Alzheimer's disease (AD). While either microglial or neuronal TLR9 activation exerts neuroprotective effects that ameliorate AD pathology and preserve cognitive function, CpG oligodeoxynucleotides (ODNs), the synthetic agonists, cannot cross the blood-brain barrier (BBB). To overcome this, we developed tNCpG, an apolipoprotein E (ApoE)-functionalized polymersome nanocarr...

Metadata
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
10%
Debates
0
Incoming
2
Outgoing
2
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.